Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole for endometrial thickness in IVF candidate women
IRCT20120104008611N14Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of letrozole in female infertility (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Endometrial thickness, Biochemical pregnancy and 1 more. Started Jul 2023; status: completed.
02
Drugs
letrozole
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20120104008611N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120104008611N14.